4//SEC Filing
Leggett Thomas 4
Accession 0001415889-24-013477
CIK 0001623526other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 4:14 PM ET
Size
5.6 KB
Accession
0001415889-24-013477
Insider Transaction Report
Form 4
Leggett Thomas
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-05-15+396,200→ 396,200 totalExercise: $14.13Exp: 2034-05-14→ Common Stock (396,200 underlying)
Footnotes (1)
- [F1]The stock option vests as to 1/4 of the total award on May 7, 2025, and as to 1/48 of the total award monthly thereafter, subject to the reporting person's continued service to the Issuer on each vesting date.
Documents
Issuer
Stoke Therapeutics, Inc.
CIK 0001623526
Entity typeother
Related Parties
1- filerCIK 0001774690
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 4:14 PM ET
- Size
- 5.6 KB